Volume 90, Issue 6
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645



Therapy for mansonelliasis is challenging because there is no standard drug recommended for its treatment. This non-randomized study was conducted to evaluate the effectiveness of a single dose of 0.15 mg/kg of ivermectin to reduce microfilaraemia in infected persons. A total of 74 patients were studied within the municipality of Lábrea, which is located in Amazonas State, Brazil. The patients were treated with ivermectin after detection of the parasite by blood examination. Significant microfilaraemia reduction was observed and its residual effect was maintained for at least 12 months. There was no significant change in the laboratory blood count, hepatic metabolites, and nitrogen-bounding compound excreta dosage values that could compromise the use of this drug, demonstrating that ivermectin has a low toxicity level.


Article metrics loading...

The graphs shown below represent data from March 2017
Loading full text...

Full text loading...



  1. Tavares AM, Fraiha Neto H, Leão RN, , 1997. Mansonelose. , ed. Doenças Infecciosas e Parasitárias, Enfoque Amazônico. Belém, Brazil: UEPA/Instituto Evandro Chagas, 733737. [Google Scholar]
  2. Cerqueira NL, , 1959. Sobre a transmissão da Mansonella ozzardi . J Bras Med 1: 885914. [Google Scholar]
  3. Shelley AJ, Coscarón S, , 2001. Simuliid blackflies (Diptera: Simuliidae) and Ceratopogonide midges (Diptera: Ceratopogonidae) as vectors of Mansonella ozzardi (Nematoda: Onchocercidae) in northern Argentina. Mem Inst Oswaldo Cruz 96: 451458. [Google Scholar]
  4. Deane MP, , 1949. Sobre a incidência de filárias humanas em Manaus, estado do Amazonas. Rev Serv Esp Saude Publ 2: 849858. [Google Scholar]
  5. Lacerda NB, Rachou RG, , 1956. Filarioses humanas nas sedes municipais do Estado do Amazonas e territórios do Acre, Guaporé Rio Branco. Rev Bras Malariol Doencas Trop 8: 437442. [Google Scholar]
  6. Moraes MA, , 1959. Estudo sobre a variação nictemeral da microfilaremia de Mansonella ozzardi . Hospital 56: 869873. [Google Scholar]
  7. Moraes MA, , 1976. Mansonella ozzardi microfilariae in skin snips. Trans R Soc Trop Med Hyg 70: 16. [Google Scholar]
  8. Tavares AM, , 1981. Estudo da Infecção por Mansonella ozzardi. MsD Thesis, Universidade de Brasília, Brasília. [Google Scholar]
  9. Medeiros JF, Py-Daniel V, Barbosa UC, Ogawa GM, , 2008. Ocorrência da Mansonella ozzardi (Nematoda, Onchocercidae) em comunidades ribeirinhas do rio Purus, Município de Boca do Acre, Amazonas, Brasil. Cad Saude Publica 25: 14211426. [Google Scholar]
  10. Medeiros JF, Py-Daniel V, Barbosa UC, Izzo TJ, , 2009. Mansonella ozzardi in Brazil: prevalence of infection in riverine communities in the Purus region, in the state of Amazonas. Mem Inst Oswaldo Cruz 104: 7480.[Crossref] [Google Scholar]
  11. Medeiros JF, Py-Daniel V, Barbosa UC, , 2011. Prevalence of Mansonella ozzardi among riverine communities in the Labrea municipality, State of Amazonas, Brazil. Rev Soc Bras Med Trop 44: 186190.[Crossref] [Google Scholar]
  12. Batista D, Oliveira WR, Rabello VD, , 1960. Estudo da patogenicidade da Mansonella ozzardi e da sintomatologia da mansonelose. Rev Inst Med Trop Sao Paulo 2: 281289. [Google Scholar]
  13. Oliveira WR, , 1961. Filarioses humanas na cidade de Manaus. Hospital 56: 301303. [Google Scholar]
  14. Branco BC, Chamom W, Belfort Neto R, Belfort JR, Costa AJA, , 1998. Achados oculares entre habitantes do município de Pauini e possível associação entre lesões corneanas e mansonelose na Amazônia. Arq Bras Oftalmol 61: 674682. [Google Scholar]
  15. Garrido C, Campos M, , 2001. First report of presumed parasititic keratitis in indians from the Brazilian Amazon. Cornea 19: 817819.[Crossref] [Google Scholar]
  16. Vianna LMM, Martins M, Cohen MJ, Cohen JM, Belfort R, Jr, 2012. Mansonella ozzardi corneal lesions in the Amazon: a cross-sectional study. BMJ Open 27: 15. [Google Scholar]
  17. Bartoloni A, Cancrini G, Bartalesi F, Marcolin D, Roselli M, Arce CC, Hall AJ, , 1999. Mansonella ozzardi infection in Bolivia: prevalence and clinical associations in the Chaco region. Am J Trop Med Hyg 61: 830833. [Google Scholar]
  18. Gonzalez AA, Chadee DD, Rawlins SC, , 1999. Ivermectin treatment of mansonellosis in Trinidad. West Indian Med J 48: 231234. [Google Scholar]
  19. Nutman TB, Nash TE, Ottesen EA, , 1987. Ivermectin in the successful treatment of a patient with Mansonella ozzardi infection. J Infect Dis 156: 662665.[Crossref] [Google Scholar]
  20. Bisoffi Z, Buonfrate D, Angheben A, Boscolo M, Anselmi M, Marocco S, Monteiro G, Gobbo M, Bisoffi G, Gobbi F, , 2011. Randomized clinical trial on ivermectin versus thiabendazole for the treatment of strongyloidiasis. PLoS Negl Trop Dis 5: e1254.[Crossref] [Google Scholar]
  21. Suputtamongkol Y, Kungpanichkul N, Silpasakorn S, Beeching NJ, , 2008. Efficacy and safety of a single-dose veterinary preparation of ivermectin versus 7-day high-dose albendazole for chronic strongyloidiasis. Int J Antimicrob Agents 31: 4649.[Crossref] [Google Scholar]
  22. Wen LY, Yan XL, Sun FH, Fang YY, Yang MJ, Lou LJ, , 2008. A randomized, double-blind, multicenter clinical trial on the efficacy of ivermectin against intestinal nematode infections in China. Acta Trop 106: 190194.[Crossref] [Google Scholar]
  23. Naquira C, Jimenez G, Guerra JG, Bernal R, Nalin DR, Neu D, Aziz M, , 1989. Ivermectin for human strongyloidiasis and other intestinal helminths. Am J Trop Med Hyg 40: 304309. [Google Scholar]
  24. Araújo CF, Fernandez CL, , 2005. Prevalência de parasitoses intestinais na cidade de Eirunepé, Amazonas. Rev Soc Bras Med Trop 38: 69.[Crossref] [Google Scholar]
  25. Gómez J, Magris M, Marín A, Frontado H, Rangel T, Botto C, , 2000. Estudio del efecto de ivermectina en helmintos intestinales en comunidades yanomamis del Alto Orinoco Estado Amazonas Venezuela. Bol Soc Venez Microbiol 20: 131134. [Google Scholar]
  26. Instituto Brasileiro de Geografia e Estatística – IBGE, 2010. Populações e Domicílios – Brasil, Censo 2007. Available at: http://www.ibge.gov.br/home. Accessed February 10, 2012. [Google Scholar]
  27. Deeks JJ, Dinnes J, D'Amico R, Sowden AJ, Sakarovitch C, Song F, Petticrew M, Altman DG, , 2003. Evaluating non-randomised intervention studies. Health Technol Assess 7: 1173.[Crossref] [Google Scholar]
  28. Chularerk P, Desowitz RS, , 1970. A simplified membrane filtration technique for the diagnosis of microfilaraemia. J Parasitol 56: 623624.[Crossref] [Google Scholar]
  29. Ottesen EA, Campbell WC, , 1994. Ivermectin in human medicine. J Antimicrob Chemother 34: 195203.[Crossref] [Google Scholar]
  30. Vera LJ, Basano SA, Camargo JS, França AK, Ferreira RG, Casseb AA, Medeiros JF, Fontes G, Camargo LM, , 2011. Improvement of a PCR test to diagnose infection by Mansonella ozzardi . Rev Soc Bras Med Trop 44: 380382.[Crossref] [Google Scholar]
  31. Aziz MA, Diallo S, Diop IM, Lariviere M, Porta M, , 1982. Efficacy and tolerance of ivermectin in human onchocerciasis. Lancet 2: 171173.[Crossref] [Google Scholar]
  32. Fischer P, Buttner DW, Bamuhiiga J, Willians SA, , 1998. Detection of the filarial parasite Mansonella streptocerca in skin biopsies by a nested polymerase chain reaction-based assay. Am J Trop Med Hyg 58: 816820. [Google Scholar]
  33. Fischer P, Tukesiga E, Buttner D, , 1999. Long term suppression of Mansonella streptocerca microfilariae after treatment with ivermectin. J Infect Dis 180: 14031405.[Crossref] [Google Scholar]
  34. Kyelem D, Sanou S, Boatin B, Medlock J, Coulibaly S, , 2003. Impact of long-term ivermectin (Mectizan) on Wuchereria bancrofti and Mansonella perstans infections in Burkina Faso: strategic and policy implications. Ann Trop Med Parasitol 97: 827838.[Crossref] [Google Scholar]
  35. Kyelem D, Medlock J, Sanou S, Bonkoungou M, Boatin B, , 2005. Impact of long-term (14 years) bi-annual ivermectin on Wuchereria bancrofti microfilaraemia. Trop Med Int Health 10: 10021004.[Crossref] [Google Scholar]
  36. Mas J, Ascaso C, Escaramis G, Abellana R, Duran E, , 2006. Reduction in the prevalence and intensity of infection in Onchorcerca volvulus microfilariae according to ethnicity and community after 8 years of ivermectin treatment on the island of Bioko, Equatorial Guinea. Trop Med Int Health 11: 10821091.[Crossref] [Google Scholar]
  37. Canga AG, Prieto MA, Liébana MJ, Martínez NF, Veja MS, , 2008. The pharmacokinets and interactions of ivermectin in humans – A mini-review. AAPS J 10: 4246.[Crossref] [Google Scholar]
  38. Krolewiecki AJ, Cajal SP, Villalpando C, Gil JF, , 2011. Invermectin-related adverse clinical events in patients treated for Mansonella ozzardi infections. Rev Arg Microb 43: 4850. [Google Scholar]
  39. Prichard RK, Basáñez MG, Boatin BA, McCarthy JS, García HH, Yang GJ, Sripa B, Lustigman S, , 2012. A research agenda for helminth diseases of humans: intervention for control and elimination. PLoS Negl Trop Dis 6: e1549.[Crossref] [Google Scholar]

Data & Media loading...

  • Received : 14 Jul 2013
  • Accepted : 16 Feb 2014
  • Published online : 04 Jun 2014

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error